SCHEMBL20090159

SCHEMBL20090159

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc(-c3ccc4c(c3)c3c5ccccc5ccc3c3nc5ccc(-c6cccc7ccccc67)cc5n43)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.36
KMT2A Q03164 4/20 0.35
CAMKK1 Q8N5S9 2/20 0.35
CAMKK2 Q96RR4 2/20 0.35
MEN1 O00255 2/20 0.35
CYP1A2 P05177 2/20 0.35
MAPT P10636 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
BCL2 P10415 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
PIM3 Q86V86 1/20 0.33
DYRK2 Q92630 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
PIM2 Q9P1W9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20090155 0.96 AHR (0.34) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL20090174 0.94 AHR (0.33) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL20090162 0.93 AHR (0.34) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL19960274 0.90 AHR (0.37) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL20090169 0.90 AHR (0.33) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL19960301 0.90 KMT2A (0.35) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL20090243 0.89 AHR (0.33) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL20090181 0.89 MET (0.33) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL19960276 0.89 ALDH1A1 (0.36) AHRKMT2ACAMKK1CAMKK2MEN1
SCHEMBL20090134 0.88 KMT2A (0.43) AHRKMT2ACAMKK1CAMKK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 AHR 58/4885KMT2A 443/4885CAMKK1 4412/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 AHR 58/4885KMT2A 443/4885CAMKK1 4412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.